172 related articles for article (PubMed ID: 29344672)
1. Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells.
Gao L; Sun X; Zhang Q; Chen X; Zhao T; Lu L; Zhang J; Hong Y
Mol Med Rep; 2018 Mar; 17(3):4345-4350. PubMed ID: 29344672
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways.
Zhang J; Ng S; Wang J; Zhou J; Tan SH; Yang N; Lin Q; Xia D; Shen HM
Autophagy; 2015 Apr; 11(4):629-42. PubMed ID: 25919885
[TBL] [Abstract][Full Text] [Related]
3. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
4. PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.
Chen L; Jin T; Zhu K; Piao Y; Quan T; Quan C; Lin Z
Oncotarget; 2017 Feb; 8(7):11937-11949. PubMed ID: 28060760
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A activates FOXO1 and induces autophagy in osteosarcoma.
Bai Y; Chen Y; Chen X; Jiang J; Wang X; Wang L; Wang J; Zhang J; Gao L
Arch Med Sci; 2019 Jan; 15(1):204-213. PubMed ID: 30697272
[TBL] [Abstract][Full Text] [Related]
8. The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.
Ishii D; Shindo Y; Arai W; Konno T; Kohno T; Honda K; Miyajima M; Watanabe A; Kojima T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338691
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
Zhang P; Guo Z; Wu Y; Hu R; Du J; He X; Jiao X; Zhu X
PLoS One; 2015; 10(8):e0136193. PubMed ID: 26287365
[TBL] [Abstract][Full Text] [Related]
11. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
Wilson-Edell KA; Yevtushenko MA; Rothschild DE; Rogers AN; Benz CC
Breast Cancer Res Treat; 2014 Apr; 144(2):287-298. PubMed ID: 24562770
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells.
Liu J; Livingston MJ; Dong G; Tang C; Su Y; Wu G; Yin XM; Dong Z
Cell Death Dis; 2018 Feb; 9(3):322. PubMed ID: 29476062
[TBL] [Abstract][Full Text] [Related]
13. Histone Deacetylase Inhibitor Trichostatin A Suppresses Cell Proliferation and Induces Apoptosis by Regulating the PI3K/AKT Signalling Pathway in Gastric Cancer Cells.
An X; Wei Z; Ran B; Tian H; Gu H; Liu Y; Cui H; Zhu S
Anticancer Agents Med Chem; 2020; 20(17):2114-2124. PubMed ID: 32593284
[TBL] [Abstract][Full Text] [Related]
14. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Im JY; Kim J; Choi WS; Kim HS
Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
[TBL] [Abstract][Full Text] [Related]
15. Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma.
Körholz K; Ridinger J; Krunic D; Najafi S; Gerloff XF; Frese K; Meder B; Peterziel H; Vega-Rubin-de-Celis S; Witt O; Oehme I
Cells; 2021 Apr; 10(5):. PubMed ID: 33923163
[TBL] [Abstract][Full Text] [Related]
16. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN
Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781
[TBL] [Abstract][Full Text] [Related]
17. Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma.
Lin WC; Hsu FS; Kuo KL; Liu SH; Shun CT; Shi CS; Chang HC; Tsai YC; Lin MC; Wu JT; Kuo Y; Chow PM; Liao SM; Yang SP; Hong JY; Huang KH
J Mol Med (Berl); 2018 Dec; 96(12):1307-1318. PubMed ID: 30288546
[TBL] [Abstract][Full Text] [Related]
18. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A Induces Autophagy in Cervical Cancer Cells by Regulating the PRMT5-STC1-TRPV6-JNK Pathway.
Liu JH; Cao YM; Rong ZP; Ding J; Pan X
Pharmacology; 2021; 106(1-2):60-69. PubMed ID: 33142290
[TBL] [Abstract][Full Text] [Related]
20. Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.
Dupéré-Richer D; Kinal M; Ménasché V; Nielsen TH; Del Rincon S; Pettersson F; Miller WH
Cell Death Dis; 2013 Feb; 4(2):e486. PubMed ID: 23392174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
